OncoCyte (BTX) Adds Andrew Last as Director
Tweet Send to a Friend
OncoCyte Corporation (“OncoCyte”), a company focused on non-invasive cancer diagnostics, announced the appointment of Dr. Andrew J. Last as an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


